ClinicalTrials.gov record
A Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis
ClinicalTrials.gov ID: NCT03759041
Public ClinicalTrials.gov record NCT03759041. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ECO-RESET: A Phase 2B, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose, Multicenter Study to Assess Efficacy and Safety of SER-287 in Adults With Active Mild-to-Moderate Ulcerative Colitis
Study identification
- NCT ID
- NCT03759041
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Seres Therapeutics, Inc.
- Industry
- Enrollment
- 203 participants
Conditions and interventions
Conditions
Interventions
- Vancomycin Pre-Treatment Drug
- Placebo for Vancomycin Pre-Treatment Drug
- SER-287 Drug
- Placebo for SER-287 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 18, 2018
- Primary completion
- May 27, 2021
- Completion
- Oct 12, 2021
- Last update posted
- Aug 11, 2022
2018 – 2021
United States locations
- U.S. sites
- 81
- U.S. states
- 28
- U.S. cities
- 73
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| (Investigator site) | Phoenix | Arizona | 85018 | — |
| (Investigator site) | North Little Rock | Arkansas | 72117 | — |
| (Investigator site) | La Jolla | California | 92037 | — |
| (Investigator site) | Lancaster | California | 93534 | — |
| (Investigator site) | Los Angeles | California | 90067 | — |
| (Investigator site) | Mountain View | California | 94040 | — |
| (Investigator site) | San Diego | California | 92103 | — |
| (Investigator site) | San Diego | California | 92123 | — |
| (Investigator site) | Wheat Ridge | Colorado | 80033 | — |
| (Investigator site) | Danbury | Connecticut | 06810 | — |
| (Investigator site) | Hamden | Connecticut | 06518 | — |
| (Investigator site) | Boca Raton | Florida | 33487 | — |
| (Investigator site) | Clearwater | Florida | 33762 | — |
| (Investigator site) | Crystal River | Florida | 34429 | — |
| (Investigator site) | Fort Lauderdale | Florida | 33308 | — |
| (Investigator site) | Hialeah | Florida | 33012 | — |
| (Investigator site) | Jacksonville | Florida | 32256 | — |
| (Investigator site) | Miami | Florida | 33136 | — |
| (Investigator site) | Miami | Florida | 33176 | — |
| (Investigator site) | Naples | Florida | 34102 | — |
| (Investigator site) | Ocala | Florida | 34474 | — |
| (Investigator site) | Orlando | Florida | 32803 | — |
| (Investigator site) | Pompano Beach | Florida | 33060 | — |
| (Investigator site) | Port Orange | Florida | 32127 | — |
| (Investigator site) | Tampa | Florida | 33609 | — |
| (Investigator site) | Athens | Georgia | 30607 | — |
| (Investigator site) | Atlanta | Georgia | 30322 | — |
| (Investigator site) | Marietta | Georgia | 30060 | — |
| (Investigator site) | Chicago | Illinois | 60611 | — |
| (Investigator site) | Chicago | Illinois | 60612 | — |
| (Investigator site) | Chicago | Illinois | 60637 | — |
| (Investigator site) | Indianapolis | Indiana | 46202 | — |
| (Investigator site) | Lexington | Kentucky | 40536 | — |
| (Investigator site) | Lake Charles | Louisiana | 70601 | — |
| (Investigator site) | Metairie | Louisiana | 70006 | — |
| (Investigator site) | Monroe | Louisiana | 71201 | — |
| (Investigator site) | New Orleans | Louisiana | 70121 | — |
| (Investigator site) | Shreveport | Louisiana | 71105 | — |
| (Investigator site) | Baltimore | Maryland | 21287 | — |
| (Investigator site) | Glen Burnie | Maryland | 21208 | — |
| (Investigator site) | Ann Arbor | Michigan | 48109 | — |
| (Investigator site) | Farmington Hills | Michigan | 48334 | — |
| (Investigator site) | Rochester | Minnesota | 55905 | — |
| (Investigator site) | Bridgeton | Missouri | 63044 | — |
| (Investigator site) | Creve Coeur | Missouri | 63141 | — |
| (Investigator site) | Las Vegas | Nevada | 89123 | — |
| (Investigator site) | Reno | Nevada | 89511 | — |
| (Investigator site) | Lebanon | New Hampshire | 03756 | — |
| (Investigator site) | Great Neck | New York | 11021 | — |
| (Investigator site) | Hartsdale | New York | 10530 | — |
| (Investigator site) | New York | New York | 10016 | — |
| (Investigator site) | New York | New York | 10032 | — |
| (Investigator site) | Asheville | North Carolina | 28801 | — |
| (Investigator site) | Chapel Hill | North Carolina | 27599 | — |
| (Investigator site) | Durham | North Carolina | 27710 | — |
| (Investigator site) | Raleigh | North Carolina | 27612 | — |
| (Investigator site) | Winston-Salem | North Carolina | 27103 | — |
| (Investigator site) | Winston-Salem | North Carolina | 27157 | — |
| (Investigator site) | Cincinnati | Ohio | 45219 | — |
| (Investigator site) | Oklahoma City | Oklahoma | 73104 | — |
| (Investigator site) | Columbia | South Carolina | 29203 | — |
| (Investigator site) | Greenville | South Carolina | 29615 | — |
| (Investigator site) | Memphis | Tennessee | 38119 | — |
| (Investigator site) | Nashville | Tennessee | 37212 | — |
| (Investigator site) | Bedford | Texas | 76022 | — |
| (Investigator site) | Fort Sam Houston | Texas | 78219 | — |
| (Investigator site) | Houston | Texas | 77030 | — |
| (Investigator site) | Houston | Texas | 77043 | — |
| (Investigator site) | Houston | Texas | 77090 | — |
| (Investigator site) | McAllen | Texas | 78504 | — |
| (Investigator site) | San Antonio | Texas | 78229 | — |
| (Investigator site) | Temple | Texas | 76508 | — |
| (Investigator site) | Ogden | Utah | 84405 | — |
| (Investigator site) | Salt Lake City | Utah | 84124 | — |
| (Investigator site) | Leesburg | Virginia | 20176 | — |
| (Investigator site) | Lynchburg | Virginia | 24502 | — |
| (Investigator site) | Reston | Virginia | 20191 | — |
| (Investigator site) | Richmond | Virginia | 23249 | — |
| (Investigator site) | Spokane | Washington | 99202 | — |
| (Investigator site) | Madison | Wisconsin | 53792 | — |
| (Investigator site) | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03759041, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 11, 2022 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03759041 live on ClinicalTrials.gov.